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Aims: Isosteviol is an active derivative of stevioside and also possessing an anti-
hypertensive effect in our previous report. Left ventricular hypertrophy is an 
independent cardiovascular risk factor related to cardiovascular complications in 
patients with hypertension. Therefore, a decrease in left ventricular mass is a 
therapeutic goal in these patients. In the present study, we elucidate the anti-
hypertrophy and molecular mechanisms of isosteviol on endothelin-1(ET-1)-induced 
hypertrophy of neonatal rat cardiomyocytes. 
 
Methods: Cultured neonatal rat cardiomyocytes were stimulated with ET-1, [3H]-
leucine incorporation, and the beta-myosin heavy chain promoter activity were 
measured. We also examined the effects of isosteviol on ET-1-induced intracellular 
ROS generation and the NADPH oxidase activity. The influence of the stress pathway 
by isosteviol on the increase of ROS by ET-1 and ET-1-induced extracellular signal-
regulated kinase (ERK) phosphorylation also examined. ANOVA was used for 
statistical analysis, p < 0.05 were considered significant.   
 
Results: Isosteviol inhibited the increase of ET-1-induced of [3H]-leucine 
incorporation and intracellular ROS levels in a concentration-dependent manner. The 
increase of ROS and NADPH oxidase activity by ET-1 was significantly inhibited by 
isosteviol and N-acetylcysteine (anti-oxidant). Isosteviol also inhibited ET-1-induced 
ERK phosphorylation. These data indicate that isosteviol inhibits ET-1-induced the 
increase of ROS, NADPH oxidase activity, ERK phosphorylation, [3H]-leucine 
incorporation and subsequent hypertrophy via its antioxidant ability. 
 
Conclusions: The inhibition of NADPH oxidase activity and ROS level in ET-1 
stimulated cardiomyocytes by isosteviol were play an important part in its anti-
hypertrophy effect. These results support the therapeutic potential of isosteviol in the 
prevention of cardiomyocyte hypertrophy. 
